NOTE: LANGUAGE FROM 2017 LOI -- SUBJECT TO CHANGE WHEN CURRENT OPPORTUNITY’S LOI IS RELEASED IN MID-DECEMBER 2018
The Dana Foundation's neuroimaging research program focuses on improving human brain and brain-immune functioning to promote health, and prevent and treat disease. Funds support pilot-testing by investigators, who are early in their research careers, to enable them to pursue promising, high-risk, and innovative ideas that have a direct clinical application. The pilot data are anticipated to help increase competitiveness for seeking larger-scale support from other funders. Grant amounts for each study may be up to $200,000 total, payable over three years. Applicants will be informed within eight weeks of the preliminary proposal deadline on whether they are invited to prepare full proposals.
The Program is designed to enable investigators to obtain pilot data more quickly than is possible through other funding processes. Please note that this will be The Dana Foundation's only proposal solicitation process this year, and selection will be extremely competitive.
This program, like all other Dana-supported research, is designed to improve human health. Investigations need to be applicable to human brain or brain-immune functioning or malfunctioning. To be considered for funding, submitted proposals should focus on imaging in patients or patient tissues, and healthy volunteers.
Applications for animal model studies of brain conditions or injuries will be considered only if they relate directly to humans but cannot yet feasibly be undertaken in humans, and are anticipated to be translated into human research following the three-year grant period. Such studies include research on:
Normal brain anatomy and physiology in the animal model that can help to better understand the roles of cells and networks in specific cognitive functions and how these are altered by disease or injury; and
Animal models of human diseases, either through transgenic methods or through naturally occurring or induced disease states that are directly related to the human condition. Specific criteria for animal model studies are listed in the section on Eligibility.
Previously funded studies under this program have focused primarily on:
Understanding normal brain functioning, how it is altered by disease or injury, and how it recovers or repairs;
Assessing and improving diagnostic and therapeutic approaches; and
Refining and advancing imaging technologies to address specific clinical questions.
In addition to these three general areas of continued interest, it is becoming increasingly apparent that neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, and mental illnesses, such as schizophrenia and depression, start long before they are clinically evident. The foundation, therefore, encourages studies that seek to understand developmental processes of disease, surrogate measures of early disease existence, and measures of disease progression.
The foundation invites each institution to submit one preliminary application, using either or both:
Physiological and Structural Imaging - anatomical imaging of white or gray matter and measures of physiological functioning. These proposed studies should focus on patient-oriented clinical research;
Cellular/Molecular Imaging - biochemical actions of specific brain cells, or their interactions with immune cells, which have direct clinical relevance to human health and disease. These studies may involve human tissues or animal models. Applications can involve the study of cells within neural circuits, using a combination of imaging and single-cell electrical recording, if the techniques have already been developed.
The official announcement and description of this opportunity will be found on the sponsor's website in December 2018.
up to $200,000, payable over three years
Applicants are encouraged to consult with their Associate Deans for Research prior to internal submission to assure they meet eligibility criteria and their projects meet stated program objectives.
Each U.S. medical school dean may nominate one applicant. The applicant may use either physiological/structural or cellular imaging or both. To be considered under this program, the application must be countersigned by the medical school dean.
Investigators at institutions that are affiliated with a medical school are eligible to apply only through their affiliated medical school. Projects involving collaborations with NIH intramural researchers or industry scientists are acceptable.
Support is focused on faculty researchers who have demonstrated the potential for independent research careers who are at the assistant professor level, or in the first few years of their associate professor appointment. Postdoctoral fellows are not eligible to apply. Applications from junior investigators that are an extension of the work of a senior mentor, particularly if from the same institution, are discouraged.
Funding of up to $200,000 payable over three years is provided for proposed neuroimaging studies undertaken by promising early-career investigators who have not yet been awarded more than one independent research grant (R01 from the NIH or equivalent from another federal agency).
The foundation does not provide support for indirect costs. However, up to 10 percent of the total grant award may be used to purchase equipment for the study. The balance is to be used to meet direct research costs. Research that can be supported through clinical income should not be submitted. Studies should be designed to obtain meaningful data within the grant award period of up to three years.All applicants please note:
In ONE PDF, please provide:
A one-page, 12-point font, one-inch margin cover letter, including PI name, department/division, school/college, project title and brief summary of how the project will help reveal how the human brain functions normally, how disorders and injuries alter these functions, how various therapies affect these conditions, and/or immune cell interactions with brain cells, and
An NIH or NSF style biosketch
Please send this PDF as an e-mail attachment to Stephanie Endy at email@example.com by 5pm EST December 11, 2018.
Final nominees will be notified of their selection by December 21, 2018.
Final proposal must be received by the Office of Research Administration by January 28, 2019 at 5:00pm EST.
Final proposal must be received by the sponsor by February 4, 2019 at 3:00pm EST (ANTICIPATED)